He−40d was then tested in SIRT5‐dependent SKM‐1 AML, OCI‐AML2, and MOLM‐13 cells, showing higher antiproliferative efficacy than Et−40c in all cell lines, with IC50 values between 9 and 24 μM.393. Here, SIRT5 is linked to acute myeloid leukemia.